glp-1 microdose Microdosing Program at Figura MedSpa GLP-1 Microdosing: A Medical Perspective

Mogi M, Kondo T, Mizuno Y, Nagatsu T

GLP-1s (Glucagon-Like Peptide-1 receptor agonists) are a class of medications originally developed to help manage type 2 diabetes

Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials

References: 1

This research peptide blend combines CJC-1295 (a long-acting GHRH analog) with ipamorelin (a selective ghrelin / GHS-R1a receptor agonist)

It functions primarily as a high-affinity carrier for copper (II) ions, transporting them to specific cell receptors